HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 3.790
+0.090 (2.43%)
Aug 28, 2026, 3:59 PM EST
HLS Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 56.24 | 55.5 | 56.62 | 63.07 | 61.47 | 60.01 |
Revenue Growth | -0.32% | -1.98% | -10.23% | 2.61% | 2.43% | 6.95% |
Gross Profit Gross Profit Growth | 39.41 | 39.71 | 41.96 | 49.88 | 50.76 | 50.36 |
Operating Income Operating Income Growth | -4.51 | -4.11 | -7.69 | -10.35 | -13.5 | -6.28 |
Net Income Net Income Growth | -8.57 | -12.43 | -19.66 | -27.53 | -23.6 | -13.12 |
Earnings Per Share EPS Growth | -0.27 | -0.39 | -0.62 | -0.85 | -0.73 | -0.41 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Canada Canada Growth | 43.69 | 42.47 | 42.65 | 39.29 | 37.02 | 34.69 |
United States United States Growth | 12.02 | 12.56 | 13.19 | 18.47 | 19.56 | 20.17 |
Rest of World Rest of World Growth | 0.53 | 0.48 | 0.79 | 5.31 | 4.88 | 5.15 |
Total Total Growth | 56.24 | 55.5 | 56.62 | 63.07 | 61.47 | 60.01 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13.73 | 11.72 | 17.46 | 21.95 | 20.72 | 21.18 |
Total Debt Total Debt Growth | 41.9 | 49.82 | 66.45 | 87.62 | 97.35 | 97.57 |
Net Cash (Debt) Net Cash Growth | -28.17 | -38.1 | -48.99 | -65.67 | -76.62 | -76.39 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.90 | -1.21 | -1.54 | -2.04 | -2.36 | -2.37 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 18.25 | 17.13 | 8 | 15.79 | 16.94 | 16.43 |
Capital Expenditures CapEx Growth | -0.1 | -0.21 | -0.02 | -0.04 | -0.05 | -0.05 |
Free Cash Flow Free Cash Flow Growth | 18.15 | 16.93 | 7.99 | 15.75 | 16.9 | 16.38 |
Free Cash Flow Growth | 42.58% | 111.88% | -49.28% | -6.80% | 3.14% | 76.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 70.07% | 71.55% | 74.11% | 79.07% | 82.58% | 83.92% |
Operating Margin | -8.02% | -7.40% | -13.58% | -16.41% | -21.96% | -10.47% |
Pretax Margin | -16.39% | -23.20% | -27.52% | -44.08% | -38.59% | -19.68% |
Profit Margin | -15.24% | -22.40% | -34.71% | -43.65% | -38.39% | -21.86% |
FCF Margin | 32.28% | 30.50% | 14.11% | 24.97% | 27.49% | 27.30% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.076 | 0.148 | 0.158 |
Dividend Per Share Growth | -48.76% | -6.50% | 0.69% |
Dividend Yield | 2.53% | 2.06% | 1.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 50.92 | 50.92 | 50.92 | 50.92 | 185.98 |
P/FCF Ratio | 4.55 | 6.50 | 10.87 | 6.09 | 13.92 | 23.48 |
PS Ratio | 1.47 | 1.98 | 1.53 | 1.52 | 3.83 | 6.41 |